A nanomagnetic test paper for monkeypox virus antibodies, preparation method and application thereof

By designing nanomagnetic detection test strips, using ferromagnetic nanoparticle carrier pads and nitrocellulose membranes to coat monkeypox virus antigens and antibodies, safe and simple monkeypox virus detection is achieved, and the detection difficulty in the existing technology is solved. and risk issues, providing high sensitivity and specificity of detection results.

CN118641776BActive Publication Date: 2024-11-19SCIENCE & TECHNOLOGY RESEARCH CENTER OF CHINA CUSTOMS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411096385.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-11-19
Estimated Expiration
2044-08-12

AI Technical Summary

Technical Problem

The prior art is difficult to provide a reagent that can detect monkeypox virus safely, easily operated and does not require professional personnel and professional instruments, especially when monkeypox outbreaks, the risk of transmission and detection difficulty increase.

Method used

Nanomagnetic detection test strips of monkeypox virus antibodies composed of sample pads, ferromagnetic nanoparticle carrier pads, nitrocellulose membranes, and water absorption pads were used to fix Staphylococcus aureus A through ferromagnetic nanoparticle carrier pads. Protein, coated with monkeypox virus antigen and binding antibodies, achieve detection.

Benefits of technology

It provides low-cost, strong stability, high specificity and high sensitivity detection results. It is simple to operate and does not require professional instruments to observe the results through the naked eye, effectively avoiding the risk of infection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118641776B_ABST
    Figure CN118641776B_ABST
Patent Text Reader

Abstract

The present invention relates to a nanomagnetic detection test paper for monkeypox virus antibodies, a preparation method and application thereof, and belongs to the field of biological detection reagents. The nanomagnetic detection test paper is composed of a sample pad, a ferroferric oxide magnetic nanoparticle carrier pad, a nitrocellulose membrane, and a water-absorbing pad, which are overlapped in sequence and attached to a bottom lining card. The ferroferric oxide magnetic nanoparticle carrier pad is a glass fiber membrane fixed with magnetic nanoparticles labeled with Staphylococcus aureus protein A; the nitrocellulose membrane is provided with a detection belt and a quality control belt, and the detection belt is coated with a monkeypox virus antigen; the quality control belt is coated with an antibody that can bind to SPA. The detection test paper for detecting monkeypox virus antibodies provided by the present invention has low reagent cost, strong specificity, high sensitivity, and is more than 100 times more sensitive than the colloidal gold detection result. The detection result is accurate and reliable, simple to operate, and can be operated without strong professional skills. The detection result is judged by naked eye observation, and no instrument is required for judgment, and it is easy to use.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biological detection reagents, and in particular to a nanomagnetic detection test paper for monkeypox virus antibodies, a preparation method and application thereof. Background Art

[0002] At present, outbreaks of monkeypox have been reported in North America and Europe. Monkeypox is a viral zoonosis, a natural epidemic disease caused by the monkeypox virus, which can be transmitted between animals and humans. The monkeypox virus is an enveloped double-stranded DNA virus with a rectangular shape. It can be cultured and grown in African green monkey kidney cells, causing cytopathic effects. It belongs to the genus Orthopoxvirus of the Poxviridae family. Monkeypox can be transmitted from animals to humans, such as direct contact with the blood, body fluids and damaged skin parts of infected animals, and eating infected and undercooked meat products. It can also be transmitted from person to person, and if there is face-to-face contact with the sick people, it can be transmitted through the respiratory tract. The incubation period of the monkeypox virus is usually 6 to 13 days. The initial symptoms of the disease are fever, fatigue, headache, muscle pain, swollen lymph nodes, etc. A few days later, a rash gradually appears and can be distributed on the skin of the whole body. The rash will gradually develop into blisters containing pus. After about 2 to 4 weeks, the blisters will slowly scab and fall off. Monkeypox virus can usually be diagnosed by taking skin lesion specimens from patients for viral nucleic acid testing or electron microscopy. Viral nucleic acid is positive or monkeypox virus is observed under an electron microscope, which can be confirmed. However, it requires professional testing equipment and professionals, and there is a risk of infection. How to provide a reagent that is safe, easy to operate, and can obtain test results without professionals and professional instruments is a technical problem that needs to be solved urgently. Summary of the invention

[0003] 1. Technical issues to be resolved

[0004] In order to solve the above problems in the prior art, the present invention provides a nanomagnetic detection test paper for monkeypox virus antibodies, a preparation method and application thereof.

[0005] (II) Technical solution

[0006] In order to achieve the above object, the main technical solutions adopted by the present invention include:

[0007] A nanomagnetic detection test paper for monkeypox virus antibodies comprises a sample pad, a ferroferric oxide magnetic nanoparticle carrier pad, a nitrocellulose membrane, and a water-absorbing pad, which are overlapped in sequence and attached to a bottom liner card. The ferroferric oxide magnetic nanoparticle carrier pad is a glass fiber membrane fixed with magnetic nanoparticles labeled with Staphylococcus aureus protein A (SPA); the nitrocellulose membrane is provided with a detection belt and a quality control belt, the detection belt is coated with a monkeypox virus antigen; and the quality control belt is coated with an antibody capable of binding to SPA.

[0008] In the test paper for detecting monkeypox virus antibodies as described above, preferably, the particle size of the ferrosoferric oxide magnetic nanoparticles is 15-45 nm.

[0009] For the test paper for detecting monkeypox virus antibodies as described above, preferably, the nucleotide sequence of the monkeypox virus antigen is as shown in SEQ ID NO. 1. Furthermore, the antibody that can bind to SPA is goat anti-rabbit IgG, goat anti-mouse IgG, rabbit anti-mouse IgG, goat anti-human IgG, etc.

[0010] The method for preparing the monkeypox virus antibody test paper as described above comprises the following steps:

[0011] S1. Preparing monkeypox virus antigen using the nucleotide sequence of the monkeypox virus antigen as shown in SEQ ID NO.1;

[0012] S2, SPA labeled carboxylation treated ferroferric oxide magnetic nanoparticles, sprayed on the glass fiber membrane, to prepare ferroferric oxide magnetic nanoparticle carrier pad;

[0013] S3, coating a nitrocellulose membrane, and coating the monkeypox virus recombinant protein antigen and goat anti-rabbit IgG obtained in step S1 on the nitrocellulose membrane as a detection band and a quality control band respectively;

[0014] S4, processing sample pad;

[0015] S5. Assembly of the test strip: sequentially attach the sample pad treated in step S4, the ferroferric oxide magnetic nanoparticle carrier pad labeled with SPA in step S2, the nitrocellulose membrane coated in step S3, and the absorbent pad to the backing card to obtain a monkeypox virus antibody test strip.

[0016] In the method for preparing a test paper for detecting monkeypox virus antibodies as described above, preferably, in step S2, the particle size of the ferroferric oxide magnetic nanoparticles is 15-45 nm, the concentration of the SPA label is 1.5 mg / ml, and the blocking solution is 2% BSA; after washing, the particles are resuspended in a resuspension solution containing 0.1% Tris base, 1% BSA and 2% Triton X-100 by weight.

[0017] In the method for preparing the test paper for detecting monkeypox virus antibodies as described above, preferably, in step S3, the coating concentration of the monkeypox virus antigen protein is 1.0 mg / mL, and the coating concentration of the goat anti-rabbit IgG is 1.5 mg / mL.

[0018] In the method for preparing the test paper for detecting monkeypox virus antibodies as described above, preferably, the step S4 of treating the sample pad comprises: spraying PBS containing 0.5% Tween-20 by volume and pH=7.4 on the sample pad, drying or naturally drying it for standby use;

[0019] In step S5, the absorbent pad is absorbent paper or pure cotton linter pulp filter paper.

[0020] The present invention also provides a kit for detecting monkeypox virus antibodies, which comprises the test paper for detecting monkeypox virus antibodies as described above and a TMB solution.

[0021] In the detection kit as described above, preferably, the TMB solution is a solution containing 7-20 mg / ml TMB and 0.5-5 mmol / L hydrogen peroxide, and more preferably, the TMB solution is a solution containing 10 mg / ml TMB and 0.8 mmol / L hydrogen peroxide.

[0022] (III) Beneficial effects

[0023] The beneficial effects of the present invention are:

[0024] The kit for detecting monkeypox virus antibodies provided by the present invention has low reagent cost, stable detection reagent solution, strong specificity, high sensitivity, and is more than 100 times more sensitive than the colloidal gold detection result. The detection result is accurate and reliable, and the operation is simple and can be operated without strong professional skills. The detection result can be judged by naked eye observation without the need for instrument judgment, and the use is convenient. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 This is the SDS-PAGE electrophoresis diagram of the expression of the monkeypox antibody recombinant protein of the present invention;

[0026] Figure 2 This is the SDS-PAGE electrophoresis diagram of the purified monkeypox recombinant protein of the present invention;

[0027] Figure 3 The test result of the monkeypox antibody detection kit of the present invention;

[0028] Figure 4 This is the test result of colloidal gold immunochromatographic test paper. DETAILED DESCRIPTION

[0029] The present invention utilizes ferroferric oxide magnetic nanoparticles to prepare a test paper, and the test results can be directly observed by naked eyes, without the need for professional detection instruments, and can be operated by ordinary personnel, and the recombinant antigen protein is used, the detection is safe, and the risk of infection is effectively avoided. When the test paper for the present invention is prepared, the ferroferric oxide particles are carboxylated, which is conducive to the coating reaction, and a stable structure is formed with the coating, and the immunological properties of the coating are not affected after the coating, which solves the problem of colloidal gold coating instability and reduced sensitivity when using colloidal gold test paper.

[0030] When the present invention uses magnetic nanoparticles to coat SPA to prepare a test strip, the selection of the particle size of the magnetic nanoparticles used is studied. The research results show that the particle size of the magnetic nanoparticles is preferably 20 nm. If the particle size is less than 15 nm, the antigen or antibody is difficult to coat. If the particle size is greater than 45 nm, the magnetic nanoparticles are easily aggregated, resulting in precipitation, and are therefore not suitable for preparing a test strip.

[0031] In addition, the present invention also studies the processing method of the sample pad and finds that the processing method studied by the present invention can effectively avoid nonspecific reactions and reduce the false positive detection rate.

[0032] The technical solution of the present invention is described in detail below. The reagents used in the following specific examples are conventional reagents and commercially available products unless otherwise specified, and the percentages are weight percentages unless otherwise specified.

[0033] Example 1 Preparation of Monkeypox Virus Antigen

[0034] The specific steps for preparing the recombinant antigen of monkeypox virus are as follows:

[0035] 1. Construction of recombinant plasmid

[0036] The inventors of the present invention conducted multiple experiments to select the monkeypox virus antigen, and finally selected the body envelope glycoprotein P1 of the monkeypox virus, whose amino acid sequence was referenced (GenBank sequence number: NP_042219.1), and the gene sequence was modified according to the preferred codons of Escherichia coli O127:H6, and the secondary structure of the recombinant protein was screened by bioinformatics, and verified by a large number of experiments. The optimized gene sequence finally determined is shown in SEQ ID NO.1. Its corresponding amino acid sequence is shown in SEQ ID NO.2, and Shanghai Shenggong Company was commissioned to synthesize the optimized gene sequence (SEQ ID NO.1), and the gene was cloned into the expression vector pMD-18T (purchased from Dalian TaKaRa Company) to obtain a recombinant plasmid; the recombinant plasmid was identified, and the positive clones were screened and sent to Shanghai Yingjun Company for sequencing, and the recombinant plasmid with correct sequencing was named pMD-18T-A34.

[0037] SEQ ID NO.1:ACCGTTCCAACCATGAACAACGCTAAGCTGACCTCTACCGAAACCTCTTTCAACGACAAGCAGAAGGTTACCTTCACCTGCGACTCTGGTTACTACTCTCTGGACCCTAACGCTGTTTGCGAAACCGACAAGTGGAAGTACGAAAACCCTTGCAAGAAGATGTGCACCGTTTCTGACTACGTTTCTGAATTGTACAACAAGCCTTTGTACGAAGTTAACGCTATCATCACCTTGATCTGCAAGGACGAAACCAAGTACTTCAGATGCGAAGAAAAGAACGGTAACACCTCTTGGAACGACACCGTTACCTGCCCAAACGCTGAATGCCAGTCTTTGCAGCTGGACCACGGTTCTTGCCAGCCTGTTAAGGAAAAGTACTCTTTCGGTGAACACATCACCATCAACTGCGACGTTGGTTACGAAGTTATCGGTGCTTCTTACATCACCTGCACCGCTAACTCTTGGAACGTTATCCCATCTTGCCAGCAGAAGTGCGACATCCCTTCTTTGTCTAACGGTCTGATCTCTGGTTCTACCTTCTCTATCGGTGGTGTTATCCACTTGTCTTGCAAGTCTGGTTTCATCTTGACCGGTTCTCCTTCTTCTACCTGCATCGACGGTAAGTGGAACCCAGTTTTGCCTATCTGCATCAGGTCTAACGAAGAATTCGACCCAGTTGAAGACGGTCCAGACGACGAAACCGACTTGTCTAAGTTGTCTAAGGACGTTGTTCAGTACGAACAGGAAATCGAATCTCTGGAAGCTACCTACCAC。

[0038] SEQ ID NO.2:TVPTMNNAKLTSTETSFNDKQKVTFTCDSGYYSLDPNAVCETDKWKYENPCKKMCTVSDYVSELYNKPLYEVNAIITLICKDETKYFRCEEKNGNTSWNDTVTCPNAECQSLQLDHGSCQPVKEKYS FGEHITINCDVGYEVIGASYITCTANSWNVIPSCQQKCDIPSLSNGLISGTFSIGGVIHLSCKSGFILTGSPSSTCIDGKWNPVLPICIRSNEEFDPVEDGPDDETDLSKLSKDVVQYEQEIESLEATYH.

[0039] Experimental studies have shown that if a non-optimized gene sequence is used for recombinant expression, no recombinant protein can be obtained.

[0040] 2. Expression and identification of recombinant proteins

[0041] The recombinant plasmid pMD-18T-A34 with correct sequencing was transformed into E. coli BL21 to construct the expression engineering bacteria. After processing according to the conventional method in "Molecular Cloning", it was evenly spread on LB agar plates containing 25 µg / ml Kan and 100 µg / ml ampicillin and cultured at 37°C overnight. After the colony was initially identified as positive by detection, the single colony identified correctly was inoculated into LB liquid culture medium containing 100 µg / ml ampicillin, and cultured at 30°C with shaking at 200 r / min until A 600 =0.5~0.7, induced with 1.5 mmol / L IPTG for 4 h, observed the expression of the engineered bacteria by 15% SDS-PAGE, aspirated 1 ml of bacterial solution and centrifuged at 8000 r / min for 5 min to collect the bacteria, discarded the supernatant, suspended the precipitate with 50 µl of pure water, added 50 µl of 2×SDS gel loading buffer, boiled for 15 min, centrifuged for 1 min, and took 15 µl of supernatant for 15% SDS-PAGE analysis. The results are shown in Figure 1 As shown, the band control is the uninduced bacterial solution (i.e., bacterial solution before induction), A34 is the bacterial solution after induction, and maker is the protein molecular weight standard. It shows that the specific band obtained is 55KD, which is consistent with the size of the target band.

[0042] 3. Extraction and purification of recombinant protein

[0043] E. coli BL21 was obtained according to the above steps to construct the positive engineering bacteria for expression and induced expression in 200 ml LB liquid culture medium. The precipitate was then collected by centrifugation and dissolved with 20 ml lysis buffer (20 mmol / L imidazole, 50 mmol / L NaH2PO4, 300 mmol / L NaCl), ultrasonically broken on ice, and centrifuged at 10000 r / min at 4°C for 10 min to collect the precipitate. The precipitate was washed twice with 30 mM PBS and a small amount of the washed precipitate was taken for SDS-PAGE detection. The results showed that the recombinant protein was expressed in the form of inclusion bodies. The washed precipitate (mainly containing some cell debris and inclusion bodies) was added with 8 M urea, 0.1 M NaH2PO4, 0.01 M Tris·Cl at pH 7.5, incubated on ice for 1 h to completely dissolve the inclusion bodies, centrifuged at 12000r / min for 30 minutes, and the supernatant was purified by Ni-NTA affinity chromatography column. The purified recombinant protein was dialyzed into PBS and concentrated with an ultrafiltration tube to obtain a recombinant protein with a molecular weight of about 55KD, namely, the recombinant antigen of monkeypox virus. Figure 2 As shown, M: protein molecular weight standard; A34: purified recombinant protein. 2 mg of purified recombinant protein was used to prepare polyclonal antibodies, and New Zealand white rabbits (provided by the Experimental Animal Center of the Academy of Military Medical Sciences) were immunized using conventional methods to obtain positive rabbit serum. Example 2

[0044] The preparation of a test paper for detecting monkeypox virus antibodies comprises the following steps:

[0045] 1. Take 150 μl of 2 mg / mL ferroferric oxide magnetic nanoparticle solution for carboxylation treatment (the particle size of ferroferric oxide particles is preferably 20 nm), add 200 μl 30% glutaraldehyde solution, and shake for 2.5 hours; then wash twice with 1 ml PBS, adsorb ferroferric oxide with a magnet, remove the supernatant, then add 400 μl 1.5 mg / ml SPA (Staphylococcus a protein A), shake and incubate for 1.5 hours; add 500 μl 2% BSA, shake for 30 minutes, and block; adsorb ferroferric oxide particles with a magnet, discard the supernatant, add PBS containing 0.05% Tween-20 at a concentration of 0.02 M, wash 3 times; add 1 mL of a resuspension containing 0.1% Tris base, 1% BSA and 2% Triton X-100 by weight, mix well, spray on the glass fiber membrane, and dry at 35°C for 3 hours;

[0046] A large number of experimental studies have shown that the use of the above-mentioned proportion of resuspension can obtain the optimal dispersion of magnetic particles, avoid aggregation of magnetic particles, and effectively avoid false negative results.

[0047] 2. The monkeypox virus antigen protein and goat anti-rabbit IgG prepared in Example 1 were diluted to 1.0 mg / mL and 1.5 mg / mL with PBS solution, respectively, and the diluted monkeypox virus antigen and goat anti-rabbit IgG were coated on a nitrocellulose membrane as a detection band and a quality control band using a film sprayer, and dried at 37° C. overnight;

[0048] 3. PBS containing 0.5% Tween-20 by volume, pH = 7.4, was sprayed on the glass fiber membrane to obtain a sample pad;

[0049] 4. Assembly: The sample pad made of glass cellulose membrane, the SPA-labeled magnetic nanoparticle binding pad, the coated nitrocellulose membrane, and the absorbent pad made of absorbent paper are sequentially attached to the PVC board to form a complete test strip, which is then cut into strips with a width of 4 mm and stored in a dry and dark place to obtain the test strip;

[0050] S5. Take 100 μL of negative rabbit serum and drip it on the sample pad. Only the quality control band turns brownish yellow. Take 80 μL of TMB solution (containing 10 mg / ml tetramethylbenzidine (TMB) and 0.8 mmol / L hydrogen peroxide) and drip it on the sample pad 2 minutes later. Only the color of the quality control band darkens. The result is judged after 10 minutes. The result shows that only the quality control band turns brown.

[0051] Take 150μL of positive rabbit serum immunized with monkeypox virus antigen and add it on the sample pad, and both the quality control band and the test band appear brown-yellow; and after 2 minutes, take 80μL TMB solution and add it on the sample pad, and the quality control band and the positive test band will darken within 30s. Judge the result after 10min, and both the quality control band and the test band will appear brown-yellow bands, indicating that the test strip is qualified and can be used for monkeypox virus antibody detection.

[0052] When testing for monkeypox virus antibodies, take 150 μL of serum sample and drop it on the sample pad, and after 2 minutes, drop 80 μL of TMB solution on the sample pad, and judge the result after 10 minutes. If only the quality control band appears brownish yellow, the result is negative, indicating that the serum sample to be tested does not contain monkeypox virus antibodies; if both the quality control band and the test band appear brownish yellow, the result is positive, indicating that the serum sample to be tested contains monkeypox virus antibodies; if both bands do not show color or only the test band shows color, it means that the test strip has expired and the result is invalid.

[0053] Example 3 Sensitivity Detection

[0054] The sensitivity of the test paper for detecting monkeypox virus antibodies prepared according to Example 2 was tested.

[0055] The test strips prepared in Example 2 were used to detect monkeypox virus antibody serum, and the monkeypox virus antibody serum was diluted with fetal bovine serum to 1:100, 1:1000, 1:10000, and 1:100000; at the same time, fetal bovine serum was used as a negative control, 150 μL of serum sample was added to the sample well, and 80 μL of TMB application liquid was added to the sample pad after 2 minutes, and the results were judged for 10 minutes. The results are shown in FIG. Figure 3 In the figure, C is the quality control band; T is the detection band; 1-5 are the dilution concentrations of monkeypox virus positive serum: 1:100, 1:1000, 1:10000, 1:100000; negative control. The results show that the detection sensitivity is 1:10000.

[0056] The colloidal gold immunochromatographic test paper prepared by preparing monkeypox virus antigen is prepared as follows:

[0057] Colloidal gold was prepared by trisodium citrate reduction method, and colloidal gold immunochromatographic test paper was prepared according to conventional method, wherein SPA was used to label colloidal gold particles, the detection band on nitrocellulose membrane was coated with monkeypox virus antigen, and the quality control band was coated with goat anti-rabbit IgG, so as to obtain colloidal gold immunochromatographic test paper.

[0058] At the same time, the serum diluted 1:100, 1:1000, 1:10000, and 1:100000 prepared above was tested, but only the 1:100 serum dilution sample could be tested. The test results are shown in Figure 4 In the figure, C is the quality control band; T is the detection band; 1-4 are the dilution concentrations of monkeypox virus positive serum: 1:100, 1:1000, 1:10000, and negative control.

[0059] The above results show that the fetal bovine serum used as negative control was negative, and the prepared nanomagnetic bead immunochromatographic test paper could detect monkeypox virus antibodies diluted to 1:10000, while the colloidal gold immunochromatographic test paper could only detect monkeypox virus antibodies diluted to 1:100, with a sensitivity difference of up to 100 times.

[0060] Example 4 Specificity detection of test paper for detecting monkeypox virus antibodies

[0061] When the monkeypox virus antibody test paper prepared in Example 2 is used to detect monkeypox virus antibodies, 150 μL of serum sample is dripped on the sample pad of the test paper, and 80 μL of TMB solution is dripped on the sample pad after 2 minutes, and the result is judged for 10 minutes. If the result shows that only the quality control band appears brownish yellow, the result is negative, indicating that the serum sample to be tested does not contain monkeypox virus antibodies; if both the quality control band and the test band appear brownish yellow, the result is positive, indicating that the serum sample to be tested contains monkeypox virus antibodies; if both bands do not develop color or only the test band develops color, it means that the test strip has expired and the result is invalid.

[0062] Through the detection of monkeypox antigen-positive serum, tularemia antibody-positive serum, Legionella antibody-positive serum, and Brucella antibody-positive serum (provided by the Health Quarantine Laboratory of China Customs Science and Technology Research Center), the test results showed that only the monkeypox antigen-positive serum was positive, and the other samples were negative, indicating that the monkeypox virus antibody detection test paper of the present invention has strong specificity and the results are accurate and reliable.

[0063] Example 5 Application of the test paper of the present invention

[0064] The test strip prepared in Example 2 was used to detect 28 healthy human serum samples collected. 150 μL of serum sample was added to the sample well, and 80 μL of TMB solution was added dropwise to the sample pad 2 minutes later. The results were all negative after 10 minutes, which was consistent with the ELISA test results. The ELISA test kit was the Human Anti-Monkeypox ELISA kit purchased from AntibodySystem, France.

[0065] In the above embodiments, various processes and methods not described in detail are conventional methods well known in the art.

[0066] The above is only a preferred embodiment of the present invention, and does not limit the present invention in other forms. Any technician familiar with the profession may use the above disclosed technical content to change or modify it into an equivalent embodiment with equivalent changes. However, any simple modification, equivalent change and modification made to the above embodiment according to the technical essence of the present invention without departing from the technical solution of the present invention still belongs to the protection scope of the technical solution of the present invention.

Claims

1. A nanomagnetic test paper for monkeypox virus antibodies, characterized in that: The invention comprises a sample pad, a ferroferric oxide magnetic nanoparticle carrier pad, a nitrocellulose membrane and a water-absorbing pad, which are overlapped in sequence and attached to a bottom lining card. The ferroferric oxide magnetic nanoparticle carrier pad is a glass fiber membrane fixed with magnetic nanoparticles labeled with protein A of Staphylococcus aureus; the nitrocellulose membrane is provided with a detection belt and a quality control belt, the detection belt is coated with a monkeypox virus antigen; the quality control belt is coated with an antibody capable of binding to SPA; the particle size of the ferroferric oxide magnetic nanoparticles is 15-45 nm; the amino acid sequence of the monkeypox virus antigen is shown in SEQ ID NO.2, and the nucleotide sequence thereof is shown in SEQ ID NO.

1.

2. A method for preparing a test paper for detecting monkeypox virus antibodies, characterized in that: It includes the following steps: S1. Preparing monkeypox virus antigen using the nucleotide sequence of the monkeypox virus antigen as shown in SEQ ID NO.1; S2, SPA labeled carboxylation treated ferroferric oxide magnetic nanoparticles, sprayed on the glass fiber membrane, to prepare ferroferric oxide magnetic nanoparticle carrier pad; S3, coating a nitrocellulose membrane, and coating the monkeypox virus recombinant protein antigen and goat anti-rabbit IgG obtained in step S1 on the nitrocellulose membrane as a detection band and a quality control band respectively; S4, processing sample pad; S5, assembling the test strip: sequentially attach the sample pad treated in step S4, the ferroferric oxide magnetic nanoparticle carrier pad labeled with SPA in step S2, the nitrocellulose membrane coated in step S3, and the absorbent pad to the backing card to obtain a monkeypox virus antibody test strip; In step S2, the particle size of the ferroferric oxide magnetic nanoparticles is 15-45 nm, the concentration of the SPA label is 1.5 mg / ml, and the blocking solution is 2% BSA; after washing, the particles are resuspended in a resuspension solution containing 0.1% Tris base, 1% BSA and 2% Triton X-100 by weight; Step S4 of treating the sample pad is as follows: spraying PBS containing 0.5% Tween-20 by volume and pH=7.4 on the sample pad, and drying or naturally drying the sample pad for later use.

3. The preparation method according to claim 2, characterized in that: In step S3, the coating concentration of the monkeypox virus antigen protein is 1.0 mg / mL, and the coating concentration of the goat anti-rabbit IgG is 1.5 mg / mL.

4. The preparation method according to claim 2, characterized in that: In step S5, the absorbent pad is absorbent paper or pure cotton linter pulp filter paper.

5. A kit for detecting monkeypox virus antibodies, comprising the nanomagnetic detection test paper for monkeypox virus antibodies as claimed in claim 1 and TMB solution.

6. The kit according to claim 5, characterized in that The TMB solution is a solution containing 7-20 mg / ml TMB and 0.5-5 mmol / L hydrogen peroxide.